Drug Type Monoclonal antibody |
Synonyms 211AT-B10-1F5 |
Target |
Mechanism CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Burkitt Lymphoma | Discovery | US | - | |
Burkitt Lymphoma | Discovery | US | - | |
Burkitt Lymphoma | Discovery | SE | - |